Health Care Equipment & Services

Insider sales spike at BETA BIONICS as CCO Mark Hopman sells 821 shares—explore what this means for the company’s future and your portfolio.

BrightSpring Health Services insider sales reveal gradual divestment, yet strong tech‑driven growth and robust market cap suggest long‑term upside for investors.

CEO Ritchey Clay Brian’s RSU grant at Definitive Healthcare signals board confidence and long‑term alignment, hinting at potential upside amid recent insider selling.

Insider sales at PACS Group stay routine in the bull market, with CEO Murray Hulse’s recent 10b5‑1 sell showing no warning and the stock’s fundamentals remain strong.

Insightful analysis of HEARTFLOW Inc.’s 10b5‑1 insider trades reveals disciplined buying and strategic selling amid a rising 48% YTD stock rally, underscoring confidence in its cardiovascular pipeline and market position.

Insider sale: ResMed’s Global General Counsel sells 400 shares under a Rule 10b5‑1 plan—no market shock, just disciplined, compliant risk management.

How Kaye Mark’s insider sales signal Elevance Health’s confidence and liquidity strategy amid rising shares and robust earnings.

WCAS XII’s 1.5‑million‑share divestiture of Innovage reveals how institutional investors value tech‑driven healthcare firms that drive value‑based reimbursement, scalable cloud platforms, and sustainable revenue, shaping future capital allocation an…

Ignite Aggregator LP’s recent 1.5 M‑share sale of Innovage Holding at $9.25 signals a tactical divestiture near the stock’s 52‑week high, raising clues for investors on valuation, liquidity, and upcoming board actions.

Discover how KESTRA MEDICAL’s rule‑based insider trades reveal a disciplined liquidity strategy and growing confidence in its medical technology leadership.